From HTS codes and duty models to heavy metal limits, contract stability, and IP protection — every critical question answered by Blue Eyes Bio UK, your partner for high‑purity botanical extracts.
Why this guide now: In April 2026, supplement brands in the US and EU face a triple squeeze: volatile raw material prices, new tariff surcharges, and tightening regulatory scrutiny on botanical ingredients. This white paper addresses the 10 most frequent and conversion‑critical questions we receive from procurement, QA, R&D, and supply chain leaders — and shows exactly how Blue Eyes Bio removes risk.
“Given the current Section 301‑related surcharges and post‑IEEPA 2026 framework, how exactly are your green tea extract shipments to the US coded under HTS 0902 and what is your 2026‑calculated duty exposure?”
This is the single most frequent question we receive from US supplement brands, and the answer is more straightforward than many assume.
HTS classification: Our green tea extract (non‑fermented, powdered extract from Camellia sinensis leaves) is properly coded under HTS 0902.10 (green tea in immediate packings ≤3 kg) or HTS 0902.20 (other green tea). These codes fall under Chapter 9, which has historically been excluded from the punitive Section 301 duties that hit many Chinese imports. As of April 2026, there is no additional Section 301 duty on these HTS lines.
Section 122 surcharge (IEEPA): The only new duty exposure is the 10% Section 122 surcharge implemented under the International Emergency Economic Powers Act, in effect through July 24, 2026. This 10% applies to the CIF value, on top of any standard MFN duty (which is often zero for tea extracts). If the surcharge lapses or changes after July 24, we will adjust quotes accordingly.
Landed‑cost modelling: We don’t just give you an EX‑W price. Every quote includes a detailed landed‑cost breakdown: EX‑W Hangzhou, freight (sea or air), insurance, and the exact Section 122 duty line item. We also provide post‑July 2026 scenarios showing what your cost looks like if the surcharge is extended, reduced, or removed. This lets your finance team budget with confidence across 2026‑2028.
What you can expect in our quote:
If you’re building a multi‑year cost model, we can also lock in a duty‑sharing clause: if the 122 surcharge rises beyond 12.5%, we split the excess 50/50, keeping your upside capped.
“With Chinese green tea prices up sharply in Q1 2026 due to weather‑driven shortages, how are you protecting contract‑price stability for EGCG 50–98% through 2026–2027, and can you share your current price‑escalation and allocation‑risk clauses?”
Raw green tea leaf prices surged approximately 22% in the first quarter of 2026, driven by frost damage in Zhejiang and increased global demand for functional beverages. That volatility is real, but our contract design insulates you from it.
Index‑linked pricing: We tie your contract price to the China Green Tea Auction Index (published by the China Tea Marketing Association) or, for EGCG‑specific grades, to a blended raw‑leaf cost index we maintain internally. Prices are reviewed quarterly, not monthly, so you have long planning windows.
Caps and bands:
Priority allocation: For every annual contract, we reserve 20% of your forecasted volume as priority allocation. If a supply shock hits (e.g., another extreme weather event), this reserved capacity is filled first, before any spot orders. This alone saved our partners in 2025 when spot market prices spiked 35% and availability dried up.
Force majeure & alternative sourcing: Our supply chain spans three tea‑producing regions (Zhejiang, Fujian, Yunnan). If one region is impacted, we shift leaf procurement and still meet your specifications, with no price penalty beyond the index movement.
What a typical contract clause looks like:
“Contract price per kg shall be the Base EX‑W price plus the Index Adjustment (capped at +10% YoY). In the event of a declared Supply Shock, the Buyer shall have first priority on 20% of contracted monthly volume, with any shortfall beyond that subject to mutual agreement.”
“What specific heavy‑metal and pesticide‑testing limits do you apply to your green tea extract under current USP and EU‑equivalent standards, and can you provide a 2026‑dated validation report showing your internal QC limits?”
Regulatory scrutiny on botanicals has intensified dramatically in 2026. The USP monograph for green tea extract now aligns closely with EU pharmacopoeial limits, and buyers rightfully demand proof, not promises.
Heavy metal specifications (per finished extract):
| Element | USP<232>Limit (Oral) | Blue Eyes Bio Internal Limit |
|---|---|---|
| Lead (Pb) | ≤1.0 ppm | ≤0.5 ppm |
| Cadmium (Cd) | ≤0.5 ppm | ≤0.3 ppm |
| Arsenic (As) | ≤1.5 ppm | ≤1.0 ppm |
| Mercury (Hg) | ≤1.0 ppm | ≤0.1 ppm |
| Copper (Cu) | Not specified | ≤20 ppm (aligned with EU food supplements) |
Pesticide screening: We follow the EU Maximum Residue Limits (MRLs) for tea, which are stricter than USP alone. Our standard panel tests for 368 pesticides, including chlorpyrifos, acetamiprid, and glyphosate. Any detection above 0.01 mg/kg triggers a root‑cause investigation. We can also run a custom panel if your brand has a “Clean Label” or “Certified Pesticide‑Free” marketing position.
Residual solvents: Our extraction uses food‑grade ethanol and water. We test every batch for:
2026 validation report: We provide a comprehensive dossier showing 12 months of third‑party mass‑balance data, including every out‑of‑specification (OOS) event, root cause, and corrective action. This is more than a COA — it’s your regulatory due diligence checklist in one PDF. If you need to show this to an FDA investigator or an EU notified body, it’s ready.
“Are you using third‑party ISO‑17025 labs for each production batch, and can you share a 2026‑dated typical report that includes EGCG assay, moisture, ash, heavy metals, and microbiology, plus chain‑of‑custody?”
The days of accepting a factory‑only COA are over. Every batch of Blue Eyes Bio green tea extract is tested at a CNAS‑accredited ISO‑17025 laboratory (we use Intertek China and, for some EU clients, Eurofins).
What the report includes:
Chain‑of‑custody: Every report carries a QR code that links directly to the original lab report file, timestamped, with auditor credentials. The code also confirms the lot number, production date, and sample retention location. This makes your own QA audit — or a customer audit — a 30‑second exercise instead of a paperwork nightmare.
Your lab, your control: You can mandate a spot‑reanalysis at any EU‑based ISO‑17025 lab of your choice, once per quarter, at our cost. If the results differ by more than the method’s measurement uncertainty, we suspend further shipments until the deviation is resolved. In 2025, this clause was used once — and it turned out the client’s lab had an instrument calibration issue, not our product.
“Can you commit to a transparent pricing structure that separates your raw‑material surcharge, freight, and any new 2026‑specific compliance or traceability fees, and what happens if any of these change mid‑contract?”
No one likes “black‑box” pricing. Our quotes are presented in three distinct line items:
What happens when costs change mid‑contract?
This mechanism ensures that neither side absorbs a hidden shock. We’ve used this structure for three years and never had a contract dispute.
“For 2026–2027 shipments, what logistics solution do you offer—is it FOB, CIF, or DDP—and how are you optimizing duty and carbon‑cost exposure under the EU’s new CBAM‑style rules and US 2026 tariff regime?”
Incoterms we offer:
US tariff optimisation: As mentioned in Question 1, we actively monitor Section 301 and Section 122 announcements. For high‑volume clients, we recommend EX‑W + freight + duty bundled under a CIF model, which gives you a single all‑in landed cost with duty exposure capped. We also offer a quarterly review of trade policy developments and, if applicable, we will re‑classify under alternative HTS codes where legally appropriate (e.g., 2106.90 for food preparations, if the extract is formulated).
EU carbon border adjustment (CBAM): While green tea extract itself is not currently in Phase 1 of CBAM (which covers cement, iron/steel, aluminium, fertilisers, and electricity), the EU is considering expansion to agricultural products by 2027–2028. To future‑proof your supply chain, we already calculate embedded CO₂ per tonne using a life‑cycle model that covers energy use during extraction, steam generation, and inland transport to port. You receive an annual CO₂ declaration template, compatible with the EU’s proposed format. This positions your brand as an early adopter of carbon transparency — a strong retail selling point.
“How do you qualify and audit your own tea‑leaf farms and extraction partners in Zhejiang, and can you share a 2026‑updated supplier‑risk‑assessment checklist aligned with US/EU food‑safety and forced‑labor‑risk expectations?”
Supply‑chain ethics is now a board‑level topic. Our due diligence programme is designed to meet both US C‑TPAT requirements and EU Supply Chain Due Diligence Act expectations.
Audit frequency: We perform quarterly on‑site audits of all major leaf‑supply farms and extraction facilities. Each audit uses a standardised checklist covering:
Forced‑labour zero‑tolerance: Any indicator — such as limited worker freedom of movement, retention of identity documents, or recruitment fees — results in immediate suspension of that supply source. We have a confidential reporting hotline for workers and a third‑party verification body (SGS, Bureau Veritas) that conducts unannounced spot checks annually. In 2025, this process led us to replace one sub‑supplier; full documentation of that decision was shared with all contracted clients.
2026 risk‑assessment template: Upon request, we share a PDF checklist that maps our audit findings to the Sedex Members Ethical Trade Audit (SMETA) pillars, so you can integrate it directly into your own supplier scorecard. We also welcome your own auditors — the clause is in our standard supply agreement.
“Are your green tea extract processes compliant with current EU ‘organic’ and ‘natural’ labeling rules, and can you support brands that are marketing higher‑purity, low‑residual‑solvent EGCG under stricter 2026‑US/EU guidelines?”
We understand that “organic” and “natural” are not marketing fluff — they come with strict legal definitions in the EU (Regulation 2018/848) and US (NOP). Our production system accounts for both.
Organic certification: We maintain a separate, dedicated production line for organic green tea extract. It uses only EU‑recognised organic‑certified fresh leaves, and the final extract is certified under the EU Organic Regulation (certificate available on request). The organic batches are traceable back to the farm cooperative, and we do not use synthetic solvents in the extraction.
‘Natural’ claim support: For brands that label “natural source of antioxidants” or “naturally derived EGCG,” we provide a process‑map and affidavit confirming:
Low‑residual‑solvent guarantee: Our high‑purity EGCG 95% is ethanol‑de‑residualised to levels well below the pharmacopoeial limits. The typical ethyl acetate residue is below 100 ppm, and ethanol is below 500 ppm — far lower than many competitors. For clients marketing to “clean label” audiences, we can also supply supercritical CO₂‑extracted versions (available with a 4‑week lead time), though the cost is higher.
In 2026, several US states (e.g., California) are increasing enforcement on misleading “natural” claims. Our documentation gives your legal team a solid defence.
“Given increasing IP‑protection concerns on novel extraction methods, can you describe how you protect co‑development IP when we jointly optimize particle‑size, EGCG stability, or solubility for our 2026‑2028 product pipeline?”
Innovation partnerships require trust and legal clarity. Our co‑development addendum has been reviewed by IP lawyers in both the UK and the US, and it balances your right to exclusivity with our ability to serve other clients.
Standard terms:
Real example: In 2025, a sports nutrition client wanted EGCG with improved cold‑water dispersibility. We jointly developed a agglomeration process. The client owns the formulation for their pre‑workout powder; we now offer the agglomerated EGCG as a standard product to other clients under a non‑exclusive basis. Both sides continue to benefit.
“For 2026, what are your minimum order quantities and payment terms for a first‑time collaboration, and can you adjust MOQs or offer deferred payment if we commit to a 12‑month forecast?”
We understand that a first order is a test — of our product quality, our logistics, and our reliability. We make it low‑risk.
Standard first‑order terms:
12‑month forecast benefits: If you commit to a rolling 12‑month forecast (with quarterly review), we significantly improve terms:
All first‑time buyers also receive a free 25 g reference sample and a complete technical dossier before any payment. You test the product in your own lab, confirm it matches your requirements, and then we ship. If it doesn’t match, you pay nothing.
Get a 25 g sample, full landed‑cost quote (with duty model), and the technical dossier — all within 48 hours.
📦 Request Sample & Quote 📞 Book a Technical CallBlue Eyes Bio Ltd — UK Registered. ISO‑17025 batch‑tested green tea extract. Trusted by supplement brands in 10+ countries.